Calcium News and Research RSS Feed - Calcium News and Research

Calcium, the most abundant mineral in the body, is found in some foods, added to others, available as a dietary supplement, and present in some medicines (such as antacids). Calcium is required for muscle contraction, blood vessel expansion and contraction, secretion of hormones and enzymes, and transmitting impulses throughout the nervous system. The body strives to maintain constant concentrations of calcium in blood, muscle, and intercellular fluids, though less than <1% of total body calcium is needed to support these functions.

The remaining 99% of the body's calcium supply is stored in the bones and teeth where it supports their structure. Bone itself undergoes continuous remodeling, with constant resorption and deposition of calcium into new bone. The balance between bone resorption and deposition changes with age. Bone formation exceeds resorption in growing children, whereas in early and middle adulthood both processes are relatively equal. In aging adults, particularly among postmenopausal women, bone breakdown exceeds formation, resulting in bone loss that increases the risk of osteoporosis over time.
GSU scientists design new MRI technique for early detection of liver tumors

GSU scientists design new MRI technique for early detection of liver tumors

Scientists at Georgia State University with funding from the National Institute of Biomedical Imaging and Bioengineering have designed an imaging technique to detect early-stage liver tumors, and have proven it successful in mice. [More]
Nature's Bounty introduces Women's Multivitamin Gummies

Nature's Bounty introduces Women's Multivitamin Gummies

Nature's Bounty, one of the most trusted names in vitamins, supplements and nutrition, is excited to introduce its Women's Multivitamin Gummies, the newest addition to the Optimal Solutions health, beauty and wellness line. This supplement helps provide women with the nutrients needed to support a healthy, strong and beautiful body. [More]
Janssen begins rolling submission of daratumumab BLA to FDA for treatment of patients with multiple myeloma

Janssen begins rolling submission of daratumumab BLA to FDA for treatment of patients with multiple myeloma

Janssen Research & Development, LLC has initiated the rolling submission of its Biologic License Application (BLA) for daratumumab to the U.S. Food and Drug Administration (FDA) for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD), or who are double refractory to a PI and an IMiD. [More]
Cytokinetics, The ALS Association expand partnership to fight against ALS

Cytokinetics, The ALS Association expand partnership to fight against ALS

Cytokinetics, Incorporated and The ALS Association announced an expanded partnership in which the company will provide Gold Level Sponsorship of the National Walks to Defeat ALS as well as Platinum Level Sponsorship for ALS Association Golden West Chapter initiatives. [More]
New study examines appropriate use of dietary supplementation in children with ASD

New study examines appropriate use of dietary supplementation in children with ASD

Children with Autism Spectrum Disorder (ASD) are often picky eaters, which can lead parents to suspect that their children might not be getting adequate amounts of vitamins and minerals. This sometimes leads parents of children with ASD to try nutritional supplements and dietary regimens such as gluten-free and casein-free (GFCF) diets without professional supervision. [More]
New Johns Hopkins study shows re-inflating balloon after carotid stenting fuels stroke risk

New Johns Hopkins study shows re-inflating balloon after carotid stenting fuels stroke risk

After reviewing outcomes from thousands of cases, researchers at Johns Hopkins report that patients with blocked neck arteries who undergo carotid stenting to prop open the narrowed blood vessels fare decidedly worse if their surgeons re-inflate a tiny balloon in the vessel after the mesh stent is in place. [More]
Vitamin D and calcium supplements may not help relieve menopausal symptoms, reveals study

Vitamin D and calcium supplements may not help relieve menopausal symptoms, reveals study

Women who took vitamin D and calcium supplements had the same number of menopausal symptoms as women who did not take the supplements, according to a study published today in Maturitas, the official journal of the European Menopause and Andropause Society. [More]
Zinc levels linked to formation of kidney stone

Zinc levels linked to formation of kidney stone

New research on kidney stone formation reveals that zinc levels may contribute to kidney stone formation, a common urinary condition that can cause excruciating pain. The research found that zinc may be the core by which stone formation starts. [More]
Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Eisai Inc. announced today results from an investigational Phase 2 trial which showed that lenvatinib, when used in combination with everolimus, significantly extended progression-free survival (PFS) in patients with metastatic renal cell carcinoma (mRCC) versus everolimus alone. [More]
Statins reduce risk of death by 67% in CABG surgery

Statins reduce risk of death by 67% in CABG surgery

Research presented at this year's Euroanaesthesia exploring the protective effect of various heart medications that patients are taking before undergoing coronary artery bypass graft (CABG) surgery concludes that statins reduce the risk of death by two thirds, or 67 percent, while no consistent effects were seen for other medications. [More]

New study highlights the benefits of using sandwich system in organic apple orchards

In organic apple orchards, one of the most serious challenges for growers is determining ways to limit weed competition while improving soil quality and ensuring high yields of quality apples. [More]
Daratumumab achieves 29.2% overall response rate in heavily pre-treated patients with multiple myeloma

Daratumumab achieves 29.2% overall response rate in heavily pre-treated patients with multiple myeloma

Data from the international, multi-center, open-label, two-part, single-arm Phase 2 MMY2002 (SIRIUS) trial show treatment with single-agent daratumumab – an investigational, human anti-CD38 monoclonal antibody – achieved an overall response rate (ORR) of 29.2 percent (95% CI, 20.8-38.9), as assessed by an independent review committee, in heavily pre-treated patients with multiple myeloma. [More]
Second phase of Nutrition Facts Education Campaign launched in Canada

Second phase of Nutrition Facts Education Campaign launched in Canada

The Honourable Tony Clement, President of the Treasury Board, on behalf of the Honourable Rona Ambrose, Minister of Health, today launched the second phase of the Nutrition Facts Education Campaign (NFEC) to help Canadians make more informed food choices for themselves and their families. [More]
Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Amgen today announced pooled data from two pivotal Phase 3, global, randomized, placebo-controlled trials evaluating AMG 416, a novel calcimimetic, for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) receiving hemodialysis. [More]
RegenScientific gets FDA approval for Renu Gel injectable implant

RegenScientific gets FDA approval for Renu Gel injectable implant

RegenScientific announced that it has received FDA-clearance for its Renu Gel injectable implant indicated for vocal fold injection augmentation and today the company commenced shipments of this new product to physicians and hospitals in the United States. [More]
National Jewish Health researcher calls for men to be included in osteoporosis screening guidelines

National Jewish Health researcher calls for men to be included in osteoporosis screening guidelines

Most people associate osteoporosis with women. But the truth is, one in four men over the age of 50 will break a bone as a result of this condition. That's more men than will have prostate cancer, according to the National Osteoporosis Foundation. [More]
Scientists working together to help parents motivate children to increase calcium intake

Scientists working together to help parents motivate children to increase calcium intake

Scientists from 11 land-grant institutions and Brigham Young University are working together to help parents motivate children to boost calcium intake to strengthen bones and prevent bone fractures from occurring later in life. [More]
E-cigarette liquid flavors may alter key cellular functions in lung tissue

E-cigarette liquid flavors may alter key cellular functions in lung tissue

Certain flavorings used in electronic cigarette liquid may alter important cellular functions in lung tissue, according to new research presented at the 2015 American Thoracic Society International Conference. [More]
Calcivis Caries Activity Imaging System meets primary performance endpoint in first clinical study

Calcivis Caries Activity Imaging System meets primary performance endpoint in first clinical study

Calcivis, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, today announces headline results from the first clinical study of its Calcivis® Caries Activity Imaging System. [More]
Using mobile app to track intake of vitamin D and calcium

Using mobile app to track intake of vitamin D and calcium

Vitamin D is essential for the maintenance of bone health and may be implicated in other chronic diseases, as well as immunity, but adults in Canada are consistently deficient in dietary vitamin D, by nearly 400 international units per day (IU/d) on average. [More]
Advertisement
Advertisement